Lv1
40 积分 2026-04-13 加入
Syncope
1小时前
待确认
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53 -Mutated Diffuse Large B-Cell Lymphoma
1个月前
已完结
How I Treat HLH-Like Toxicities Following Immune Effector Cell Therapy
2个月前
已关闭
A Randomized Phase 2 Study of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed Hodgkin Lymphoma
3个月前
已完结
Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma
3个月前
已完结
Who will watch the watchmen: unique challenges of T-cell redirecting therapies in T-cell malignancies
3个月前
已完结
皖公网安备34019202002308
